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We present here the hypothesis that alternative poly-adenylation (APA) is dysregulated
in the brains of individuals affected by Autism Spectrum Disorder (ASD), due to
disruptions in the calcium signaling networks. APA, the process of selecting different
poly-adenylation sites on the same gene, yielding transcripts with different-length 3′
untranslated regions (UTRs), has been documented in different tissues, stages of
development and pathologic conditions. Differential use of poly-adenylation sites has
been shown to regulate the function, stability, localization and translation efficiency of
target RNAs. However, the role of APA remains rather unexplored in neurodevelopmental
conditions. In the human brain, where transcripts have the longest 3′ UTRs and are
thus likely to be under more complex post-transcriptional regulation, erratic APA could
be particularly detrimental. In the context of ASD, a condition that affects individuals
in markedly different ways and whose symptoms exhibit a spectrum of severity, APA
dysregulation could be amplified or dampened depending on the individual and the
extent of the effect on specific genes would likely vary with genetic and environmental
factors. If this hypothesis is correct, dysregulated APA events might be responsible
for certain aspects of the phenotypes associated with ASD. Evidence supporting our
hypothesis is derived from standard RNA-seq transcriptomic data but we suggest that
future experiments should focus on techniques that probe the actual poly-adenylation
site (3′ sequencing). To address issues arising from the use of post-mortem tissue and
low numbers of heterogeneous samples affected by confounding factors (such as the
age, gender and health of the individuals), carefully controlled in vitro systems will be
required to model the effect of calcium signaling dysregulation in the ASD brain.
Keywords: autism spectrum disorder, alternative poly-adenylation, RNA–seq, calcium signaling, transcription
INTRODUCTION
Transcription of eukaryotic genes ends with the recognition of a cleavage and poly-adenylation
site in the genomic sequence that signals to the transcription machinery the “end” of the gene.
APA, whereby multiple sites in the same gene compete for this role resulting in transcripts with
different 3′ UTR lengths, is recognized as a widespread mechanism for regulating gene expression
Abbreviations: ASD, autism spectrum disorder; APA, alternative poly-adenylation; DRS, direct RNA sequencing; KS,
Kolmogorov–Smirnov (test); PDUI, Percentage Distal poly(A) site Usage Index; Pol II, RNA polymerase II; RNA-seq, RNA
sequencing.
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(Elkon et al., 2013). Approximately half of all human genes
have more than one poly(A) site (Tian et al., 2005) and
this number is likely to be an underestimate, as indicated
by more recent sequencing experiments (Müller et al., 2014).
Moreover, these sites are differentially selected in different tissues
(MacDonald and McMahon, 2010; Lianoglou et al., 2013), stages
of development (Ji et al., 2009; Shepard et al., 2011) and
pathologic conditions (Sandberg et al., 2008; Rehfeld et al., 2013).
For example, transcripts in the brain have been shown to have
the longest 3′ UTRs among all other tissues (Miura et al., 2013),
whereas cancer cells seem to harbor groups of genes with both
shorter (Sandberg et al., 2008; Morris et al., 2012; Xia et al., 2014)
and longer 3′ UTRs (Morris et al., 2012), each group enriched for
different functional categories.
Increasing evidence of the role of APA in disease has led
us to explore its potential involvement in ASD. Tentative links
between ASD and APA have appeared in recent studies but all
such studies have concentrated on 3′ UTR variation in individual
genes (Table 1). For example, mutations in the MECP2 gene,
a transcriptional regulator, have been identified as the primary
cause of Rett Syndrome, a neurological disorder that shares many
of its symptoms with ASD. Although mutations in the coding
region account for the majority of Rett cases, an estimated 25–
35% of patients do not have such mutations, suggesting that their
defects may be in non-coding regions (Newnham et al., 2010),
and mutations in the 3′ UTR of MECP2 have been linked to this
disorder (Hoffbuhr et al., 2001). Of particular interest to the study
of neurodevelopmental disorders such as ASD is the fact that
the MECP2 3′ UTR is known to be developmentally regulated,
with complex patterns of expression in the mouse differentiating
brain (Coy et al., 1999) and age-dependent patterns in the human
brain (Balmer et al., 2003; Han et al., 2013). A mechanism by
which mutations in the untranslated region of this gene might
lead to dysregulation of APA and consequently gene function,
has been put forward by (Newnham et al., 2010) whose study
showed that mutating a G-rich cis-acting element in the gene’s
3′ UTR strongly affects the utilization of the proximal poly-
adenylation site. A more direct link between 3′ UTR mutations
in the MECP2 gene and autism was suggested by (Shibayama
et al., 2004) but their study included only 24 autistic samples.
The larger study by (Coutinho et al., 2007) also found variations
in the 3′ UTR sequence but only in a small subset of ASD
patients. Despite the strong bias toward the study of coding
regions and copy number variations, especially in older studies,
MECP2 is not the only gene whose 3’ UTR has been linked
to autism. Isoforms of FMR1, the gene associated with Fragile
X Syndrome, an inherited condition characterized by autistic
phenotypes, are produced in the brain from three distinct poly-
adenylation sites, but relative usage of these sites is perturbed
in mouse models of gene variants with increased CGG repeat
lengths in their 5′ UTR (Tassone et al., 2011), suggesting a
possible connection between selection of the poly-adenylation
site and Fragile X-related pathologies. In summary, there is some
evidence from previous studies that variations in the 3′ UTR
affecting APA of individual genes may be linked to autistic or
autism-related phenotypes. However, the hypothesis we present
here is novel in two ways: (a) we suggest that dysregulated APA is
a downstream effect of some other molecular disruption in ASD
(and not the cause of it) and (b) we examine the possibility of an
abnormal APA mechanism in the ASD brain, potentially affecting
multiple genes and contributing to the complex pathology of this
disorder.
ABNORMAL CALCIUM SIGNALING MAY
LEAD TO DYSREGULATION OF
ALTERNATIVE POLY-ADENYLATION IN
THE AUTISTIC BRAIN
We present here the hypothesis that a downstream effect of the
reported abnormalities in calcium signaling in ASD individuals
(Krey and Dolmetsch, 2007; Lu et al., 2012; Palmieri et al.,
2010; Schmunk et al., 2015, 2017) would be the dysregulation
of the mechanism of APA. The role of calcium signaling in
determining transcript structure and expression level in neural
cells is well documented both at individual gene (Zacharias
and Strehler, 1996; Poulsen et al., 2004; Rozic-Kotliroff and
Zisapel, 2007) and genome-wide scales (McKee et al., 2007).
In our proposed model, disruptions in the calcium signaling
response lead to abnormal RNA polymerase II (Pol II) kinetics
and pausing, with consequences on the selection of 3′ UTR
lengths, and concomitant disruption of the regulation of mRNA
localization, stability and translation (Figure 1). Disrupted
calcium homeostasis, either through disruption of the release of
intracellular stores or defects in the channels controlling the entry
to cytoplasm from the extracellular space, has been suggested
as one of the problems affecting autistic individuals (Krey and
Dolmetsch, 2007; Palmieri et al., 2010; Schmunk et al., 2015), and
mutations in a calcium channel is the single source of pathology
in the Timothy Syndrome (Splawski et al., 2004), a disorder
strongly associated with ASD.
The link between calcium concentration and APA site
selection is most likely a consequence of the role of calcium
signaling on transcriptional program activation (Ebert and
Greenberg, 2013), which is known to impact on the selection
of the poly(A) site (Ji et al., 2011). Distinct transcriptional
programs dictate the production of different isoform ratios
and consequently, the dysregulation of such programs through
aberrant signaling could be expected to impact on these ratios.
A number of studies support a pathway linking calcium signaling
to the selection of poly-adenylation site. In cultured hippocampal
neurons from rat embryos, neuronal activity via calcium
signaling triggers Pol II pausing, resulting in increased selection
of the proximal site in a number of genes targeted by MEF2, a
family of regulators of synapse development (Flavell et al., 2008).
Interestingly, genetic variants of Mef2c are linked to ASD and
Mef2c mutant mice display behaviors reminiscent of this disorder
(Harrington et al., 2016). Calcium has also been implicated in
poly-adenylation in plants: the RNA binding activity of the plant
homologue of the mammalian poly-adenylation factor CPSF30 is
regulated by calmodulin binding in a calcium-dependent manner
(Chakrabarti and Hunt, 2015). Pol II kinetics also play a role
in the selection of the poly(A) site: a slower Pol II mutant
in Drosophila was associated with more efficient use of the
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TABLE 1 | Brief summary of selected publications reporting data that support parts of our hypothesis.
Reference Brief summary of the link to our hypothesis
Studies linking the 3′ UTR or
APA of individual genes to
disorders with autistic
phenotypes
Hoffbuhr et al., 2001 This study is the first report of a genomic rearrangement implicating the 3′ UTR of the
MeCP2 gene in Rett syndrome.
Shibayama et al., 2004 The authors analyzed variants in the conserved regions of the 3′ UTR of the MeCP2 gene in
patients with autism, schizophrenia and other psychiatric diseases and found that in the
case of autistic patients the frequency of mutations was higher among affected individuals
than among controls, suggesting that the untranslated tail of this gene could be implicated
in ASD.
Coutinho et al., 2007 First study to scan the whole of the 3′ UTR of the MeCP2 gene in autistic patients. The
authors reported 12 novel mutations in the 3′ UTR of this gene.
Newnham et al., 2010 The authors suggest that, since 25–35% of Rett patients do not have mutations in the
coding parts of MeCP2, they are likely to have instead variants in other parts, including the
3′ UTR.
Tassone et al., 2011 This study shows that the 3′ UTR of brain FMR1 premutation alleles (linked to Fragile
X-associated syndromes) is regulated differently to the UTR of normal alleles, with
differential usage of poly-adenylation sites observed in the premutation tissue samples.
Studies linking ASD to aberrant
calcium signaling
Splawski et al., 2004 In this study Timothy syndrome, a disorder associated with multiple dysfunctions including
autism, is linked to a single missense mutation in the L-type calcium channel Cav1.2.
Experiments of the same group showed that this mutation impairs voltage-dependent
inactivation of the channel and leads to only partial inactivation compared with the wild type.
Krey and Dolmetsch,
2007
In this review, the authors summarize evidence that links autism to aberrant Ca2+ signaling
during the development of the central nervous system. Several genes are discussed,
including voltage-gated calcium channels, voltage-activated Na+ channels,
neurotransmitter receptors and signaling proteins. The authors also point out that mutations
associated with ASD tend to increase Ca2+ signaling, suggesting that the disorder may
arise from excessive activation of networks controlled by calcium.
Palmieri et al., 2010 This study concentrates on the gene SLC25A12, which encodes the major isoform of
mitochondrial asparate/glutamate carrier (AGC) in the brain, a protein whose activity is
regulated by intracellular calcium. This protein transports glutamate into mitochondria,
which in turn controls the respiratory chain and production of ATP by oxidative
phosphorylation. The authors show that AGC activity is increased threefold in autistic brains
in the absence of a corresponding increase in protein levels. They also show that this
increase is most likely due to increased Ca2+ levels in the autistic samples, whilst genetic
variants of the SLC25A12 locus are shown not to have an effect on AGC activity in the
samples studied.
Lu et al., 2012 In this study, SNPs in ten calcium channels are tested for their association with ASD using
data from over 2000 families affected by the disorder. Four SNPs in three calcium channels
are found to be associated with autism.
Schmunk et al., 2015 In this study calcium release mediated by inositol triphosphate (IP3) receptor channels is




Flavell et al., 2008 This study focuses on an activity-dependent gene program that controls the development
of synapses and is regulated by the transcription factor MEF2. It is shown that neuronal
activity affects the choice of the polyadenylation site, favoring proximal sites and resulting in
shorter isoforms for many MEF2 target genes. One way of activating the MEF2 gene is
through calcium influx, following increased release of neurotransmitters at synapses.
Chakrabarti and Hunt,
2015
In this study it is proposed that the plant homologue of the key poly-adenylation factor
CPSF30 in mammals is regulated by calcium in a process mediated by calmodulin binding.
Calmodulin acts as a calcium sensor and its binding to CPSF30 inhibits the RNA-binding
properties of this factor, providing a link between calcium and poly-adenylation in plants.
Studies linking kinetics of Pol II
to selection of poly-adenylation
site
Pinto et al., 2011 In this study the effect of transcription kinetics on poly-adenylation site selection is
demonstrated with the use of a Drosophila mutant, whose Pol II elongation rate is reduced
when compared with the wild type. These mutant flies favor the proximal poly-adenylation
site on the cell-cycle kinase product of the polo gene, as well as on another five Drosophila
genes with tandem poly-adenylation sites in their 3′ UTRs.
Yu and Volkert, 2013 In this study a drug that is known to decrease the rate of transcription elongation in yeast is
used to demonstrate that the effect of UV damage on poly-adenylation site selection in the
RPB2 gene is most likely due to changes in the speed of elongation as opposed to changes
in transcription induction.
This table is not meant to be comprehensive but instead highlights literature that inspired us to construct the hypothesis presented here.
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FIGURE 1 | A model for the hypothesis of APA dysregulation in the autistic brain. Our hypothesis suggests that a disruption of regulation of calcium levels in the cell
affects the kinetics and pausing of Pol II, resulting in aberrant selection of poly-adenylation sites during the transcription process. In this simplified schematic, an
excess of calcium in the autistic cell is signaled to the nucleus increasing the speed of Pol II and leading to preferential selection of the distal over the proximal
poly-adenylation sites. This, in turn, results in the inclusion of regulatory elements in the 3′ UTR, such as binding sites for miRNA or RNA-binding proteins (RBP), at
times when their presence is undesirable. These elements affect the translation efficiency or degradation rate of the mRNA in question potentially leading to less
protein product, or interfere with localization signals leading to misplaced protein. As we have no evidence for specific genes/proteins playing a major role in the
hypothesis, we have deliberately avoided labeling the molecules in this cartoon of our model. It is also important to highlight that this is only one possible scenario
that is compatible with our hypothesis but other possibilities exist, e.g., calcium levels may go down instead of up, the transcription process may lead to shorter
rather than longer mRNAs, the amount of protein produced may or may not be affected etc. In fact, it is likely that several possibilities co-exist and are applicable to
different genes, depending on the presence and levels of other factors, as well as the sequence signals integral to the mRNAs in question.
proximal poly-adenylation site (Pinto et al., 2011) and a drug-
induced reduction in transcription elongation rate alleviated
the effect of preferential selection of the distal poly(A) site in
the RPB2 yeast gene following UV damage, suggesting that
the rate of transcription plays a major role in APA (Yu and
Volkert, 2013). In summary, there are established links between
all stages of our model, from calcium signaling and neuronal
activity to Pol II kinetics and the control of APA (Table 1).
Additional regulatory mechanisms such as histone modifications
and chromatin restructuring may also constitute plausible links
in this chain of events (Spies et al., 2009; Huang et al., 2013; Lee
and Chen, 2013) and their role in aberrant APA should be probed
further in future experiments.
Although our hypothesis suggests calcium signaling
abnormalities as a potential source for aberrant APA events, we
do not claim that this is the only explanation compatible with
previous studies or the data presented here. A great number of
protein factors are involved in poly-adenylation and cleavage
but we believe that changes to the expression of isolated factors
are unlikely to be the culprit as these factors do not appear in
ASD risk gene lists and they are not highlighted in differential
expression studies of the autistic brain transcriptome. A more
likely culprit, in our opinion, would be a general cell response
to stress. In a recent study, Hollerer et al. (2016) showed that
ribotoxic stress promoted the usage of distal poly(A) sites and
suppressed proximal sites in a mammalian cell line. As this result
is in agreement with previous work linking stress response to
increased selection of distal poly(A) sites (Graber et al., 2013;
Liu et al., 2013), Hollerer et al. (2016) concluded that APA is
a widespread stress response mechanism. Although this is an
appealing explanation for the presence of differential APA events
in the autistic brain, it offers no molecular links between the
stressed cell and altered poly(A) site usage. In this aspect, we
believe that our hypothesis goes one step further in providing
a plausible molecular mechanism for differential poly(A) site
selection in ASD.
It is important to point out that we do not claim dysregulation
of APA to be the cause of autism and have no evidence to
support such a claim. Our hypothesis suggests that differential
APA events are a downstream effect of some other dysregulated
mechanism or possibly, a combination of such mechanisms. We
suggest that these mechanisms might involve calcium signaling,
as pathways controlled by calcium homeostasis are both known
to be disrupted in ASD and be responsible for the regulation
of transcriptional and post-transcriptional events. Our limited
access to experimental data does not allow us to confirm a
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link between calcium and differential APA in autism, however,
we argue below that such links are testable with the right
experimental set ups.
EVIDENCE SUPPORTING THE
HYPOTHESIS OF APA DYSREGULATION
IN THE AUTISTIC BRAIN
Significant Differential APA Events Are
Found in Transcriptomic Studies of
Post-mortem ASD Brain
Our hypothesis raises the question of whether it is possible to
find direct evidence of APA dysregulation in the autistic brain
in publicly available transcriptomic datasets. Microarray-derived
datasets are currently not amenable to this type of analysis due
to both lack of probes covering all areas of potential interest and
the great variability in individual probe signal that is practically
impossible to normalize effectively. Our analysis of four RNA-
seq datasets from the literature (Figures 2A–D) supports our
hypothesis for the case of gray matter originating from selected
regions of the brain but the diversity of the signal reflects partly
the difficulty in using data that was not designed for the specific
probing of APA. Further analysis of RNA-seq data from the Fong
et al. (2014) study adds support to our suggested mechanism
of APA dysregulation: changes to the elongation rate of Pol
II affect the selection of the poly-adenylation site. Pol II slow
and fast mutants show opposite trends in the 3′ UTR length of
their transcripts, when compared with the wild type polymerase,
with the fast mutant lengthening the 3′ UTR in a manner that
resembles the effect observed in two of the ASD/control datasets
(Figure 2E). Although the origin of the changes in the Pol II
rate are different in the Fong et al. (2014) study (mutations in
the polymerase gene) and in our hypothesis (dysregulation of
mechanisms such as calcium signaling), the end result is the same:
detectable changes to APA. Hence, both the literature and existing
transcriptomic data provide evidence supporting our model that
links dysregulation of calcium homeostasis in the ASD brain
with poly(A) site switching anomalies, mediated by calcium-
dependent signaling pathways controlling the speed and pausing
of Pol II.
An additional question raised by our hypothesis is what are
the molecular factors mediating aberrant APA site selection,
given that only a subset of genes are affected and the size of
the effect varies between genes? Our search for sequence motifs,
fold stability and distance between sites have all resulted in only
weak correlations with APA selection dysregulation. There is
some evidence that expression of some poly-adenylation factors
is linked to the APA anomalies but no single gene stands out. The
most interesting link we have found is that between variability
in APA site selection among samples from healthy individuals
and the size of the differences in site selection between ASD and
control samples (Figures 2G,H). Based on this observation, we
suggest that there is a subset of genes that are more susceptible to
environmental or genetic factors affecting poly-adenylation site
selection (possibly due to less tight regulation), and that it is this
set of genes that exhibit the largest APA anomalies in the case
of disease. In our model, normally harmless variations become
amplified or combine with other aberrant events potentially
contributing to pathological conditions.
Genes Exhibiting Differential APA Events
Are Enriched for Calcium-Driven Signal
Transduction, the Immune System and
the Cytoskeleton
The observation of differential APA events in the autistic
brain led us to explore further the genes involved in an
effort to identify potential biases in the pathways affected by
these events. We searched first for overlap of our gene lists
(of significantly differential APA events in either the Ellis or
Voineagu datasets) with the 719 ASD candidate genes listed in
the SFARI Gene module (Abrahams et al., 2013). Interestingly,
no significant overlap was found (p-value > 0.1, hypergeometric
test), suggesting that APA dysregulation is distinct from genetic
factors known to be associated with ASD. Instead, our two
lists are significantly enriched in both synaptic (p-value < 1.0e-
11 for Ellis, <1.0e-3 for Voineagu) and post-synaptic density
proteins (p-value < 1.0e-24 for Ellis, <1.0e-11 for Voineagu)
(Bayés et al., 2011) and show, in addition, significant overlap (p-
value < 1.0e-8 for Ellis, <1.0e-5 for Voineagu) with neuronal
genes responding to intracellular Ca2+ concentration (McKee
et al., 2007). Gene names for significantly overlapping lists are
given in Supplementary Table 1.
Next, we searched for over-represented pathways and gene
ontology (GO) terms in our list of affected genes using the
Bioconductor package GOseq (Young et al., 2010). We examined
29 genes associated with statistically significant APA events in
both the Voineagu and Ellis datasets (Supplementary Table 2).
The set of all expressed genes in each dataset was used as
the background set in each calculation. The analysis pointed
to 19 Reactome pathways (Figure 3) that are enriched in
both datasets, with a strong bias toward signal transduction.
More specifically, several of these pathways relate to signaling
events mediated by Rho-GTPases as well as the calcium-binding
calmodulin genes (CALM1/2/3) and genes controlled by the
cyclic AMP-response element (CRE)-binding protein (CREB).
Further support for the involvement of CREB pathways comes
from the fact that our lists of genes affected by APA dysregulation
are enriched in the presence of the CRE element in their
promoters (p-value= 0.0001 and 0.006 for the Ellis and Voineagu
datasets respectively; hypergeometric test). Moreover, there are
enriched pathways that are linked to important aspects of brain
development, such as axon guidance (Reactome ID: R-HSA-
422475) and dendritic spine development (R-HSA-3928662). The
innate immune system is also directly implicated in this list
(R-HSA-168249, R-HSA-2029482), as is the actin cytoskeleton
(R-HSA-2029482). It is worth noting that these over-represented
pathways involve only 14 of the genes in the list of 29 (CALM3,
CALM1, PPP2R1A, RHOA, ACTB, ARPC1A, EVL, CTSF, HLA-A,
PEBP1, CAMK2B, GNB2, ATP6V0C, NGFRAP1). The remaining
genes either do not map to Reactome pathways or map to
pathways that do not pass the enrichment filters.
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FIGURE 2 | Publicly available transcriptomic data supports a model of APA dysregulation in the ASD brain. (A–D) RNA-seq data for ASD and control post-mortem
brain samples from four publicly available datasets show statistically significant differential APA events, as revealed by the software DaPars-v.0.9 (Masamha et al.,
2014). Box-and-whisker plots depict the distribution of Percentage Distal poly(A) site Usage Index (PDUI) values within a set of samples, grouped by condition
(gray:control; red:ASD). The PDUI value is calculated for each gene passing the coverage thresholds of DaPars (number of genes quoted in brackets) and is a
measure of the preference of using the distal over the proximal poly(A) site (PDUI is 1, if all reads are assigned to the distal site and 0, if all reads are assigned to the
proximal site). Only statistically significant events (adjusted p-value < 0.05, Fisher exact test) are included in the box-and-whisker plots. There is a statistically
significant preference for longer 3′ UTRs (larger PDUI values) in the ASD group as compared with the control group in both the Ellis and Voineagu datasets
(p-value < 2.2e-16 and p-value = 6.2e-12 respectively for one-sided KS test between control and ASD group mean PDUIs). The Irimia and Li datasets show the
opposite trend (p-values are 0.0018 and 0.075 correspondingly) but much smaller numbers of differential events have been identified in these datasets (see also F of
this figure). (E) “Fast” mutants of Pol II affect the selection of the poly-adenylation site in a way reminiscent of the effects observed in ASD brain samples.
Box-and-whisker plots show the distribution of PDUI values for genes showing differential APA events between “fast” (orange) and “slow” (green) mutants of Pol II
(data from (Fong et al., 2014)). There is a clear preference for longer 3′ UTRs (larger PDUI values) in the case of the fast mutant (p-value = 2.9e-06, KS test),
reminiscent of the ASD group in the Ellis and Voineagu datasets (A,C). (F) Samples originating from brain gray matter display larger variations in PDUI values
compared with samples from white matter (p-value < 2.2e-16; unpaired one-sided Wilcoxon rank-sum test), offering an explanation for why we find so few
differential APA events in the Li dataset (which originates from corpus callosum, an area of the brain dominated by white matter). The box-and-whisker plots display
the range of PDUI variances calculated by DaPars for 1038 genes from the Mills dataset. The dataset originates from (Mills et al., 2015) and comprises three samples
derived from white matter and three samples derived from gray matter. The plot suggests that samples from white matter can be expected to show relatively little
variation in their PDUI values. (G,H) Genes associated with greater variance in APA site selection among neurotypical subjects also show larger PDUI group mean
differences between ASD and control subjects. Box-and-whiskers plots of the standard deviation of PDUI value within the control group are shown for genes with
the largest difference in APA site selection between ASD and control groups (top 25% of the distribution of absolute values of PDUI group mean differences) and
genes with the smallest difference (bottom 25% of the same distribution). Plots are shown for the Ellis (G) and Irimia (H) datasets but plots for the Voineagu and Li
datasets are similar (not shown). Genes with large between-group PDUI differences show much larger variability in the PDUI value within the control group in both the
Ellis and Irimia datasets (p-value = < 2.2e-16 for both datasets; unpaired, one-sided Wilcoxon rank-sum test). All plots were generated using the R statistical
software suite. The boxplot whiskers extend in all cases to the most extreme data point, which lies at no more than 1.5 times the interquartile range from the box.
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FIGURE 3 | GOseq enrichment of Reactome pathways among genes with differential APA events. Barplot of adjusted p-values for the enrichment of 19 Reactome
pathways over-represented among genes with differential APA events in both Ellis and Voineagu datasets. The pathways have been grouped according to their main
classification within Reactome, with signal transduction being the most commonly occurring classification. The vertical line indicates the chosen significance cut-off
(adjusted p-value < 0.05).
Interestingly, the pathways identified as enriched in APA
dysregulation events recapitulate the findings of several recent
studies that highlight molecular interaction networks affected by
genes implicated in ASD. For example, cyclic AMP signaling
is one of the two central hubs in a network of molecular
interactions revealed by analysis of gene expression perturbations
resulting from knockdown of a number of ASD-associated genes
in mouse primary neuron cultures (Lanz et al., 2013). The
cytoskeleton features as one of the three major clusters in the
analysis of biological pathways perturbed in ASD as a result of
de novo mutations (Chang et al., 2015) and several GO terms
relating to actin organization are associated with a functional
network revealed in a separate study of rare de novo copy
number variations (CNVs) in ASD patients (Gilman et al., 2011).
Moreover, the stability of microtubules, a major constituent of
the cytoskeleton, is impaired in cell cultures from Rett patients
affected by MeCP2 deficiency (Delépine et al., 2013). It is also
worth pointing out that signaling by Rho GTPases (one of
our enriched Reactome pathways) is linked to actin network
remodeling (Saneyoshi and Hayashi, 2012), and hence this
pathway too converges to a network relating to the cytoskeleton.
To what extent the overlap between ASD-linked pathways
and APA dysregulated ones is coincidental is difficult to establish
statistically, not least because the true range of networks affected
by ASD is not known. Hence, the examples highlighted above
are not employed here to lend extra support to our hypothesis.
However, if the hypothesis is tested and turns out to be true, links
to networks could be useful in focusing further tests, helping to
predict downstream effects or even helping to rationalize selected
phenotypic observations in ASD by linking them to molecular-
level abnormalities.
Gene Set Enrichment Analysis Links APA
Dysregulation to Pathways with
Established Links to ASD
We carried out gene-set enrichment analysis (GSEA) replacing
the more commonly used gene expression values in this type
of analysis with the PDUI values calculated by DaPars (a PDUI
value essentially measures the preponderance of the long isoform
over the short isoform in a two-site APA model). We found no
enrichment of the MSigDB (Subramanian et al., 2005) “hallmark
gene sets” using the Voineagu dataset, possibly due to the very
low number of samples in each phenotype group. However,
in the Ellis dataset, four of 16 gene sets that pass the size
filters from the hallmark sets are significantly enriched (FDR
q-value< 25%) among the ASD samples: adipogenesis, oxidative
phosphorylation, fatty acid metabolism and apoptosis. Links
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of ASD to adipogenesis and fatty acid metabolism are well-
established in the literature (Tamiji and Crawford, 2010), with
a syndromic form of the disorder (Prader–Willi) being strongly
affected by obesity, a problem that is also manifested in mouse
models of ASD (Liu et al., 2015). Apoptosis has also been
linked to autism and several relevant studies are summarized
in the review of (Wei et al., 2014). Finally, an enrichment of
the oxidative phosphorylation gene set is also not unexpected as
some studies point to a link between mitochondrial disease and
autism (e.g., Weissman et al., 2008; Giulivi et al., 2010). Hence,
all the enriched groups have known associations with ASD. No
significant enrichment is observed for the control samples.
SUGGESTIONS FOR FURTHER TESTING
OF THE HYPOTHESIS
Given our findings, extending the study to any other
transcriptomic datasets from autistic brain seems like an
obvious next step. However, our pilot studies of publicly available
RNA-seq datasets have revealed several caveats of using RNA-seq
to study APA. First, software that identifies APA sites from the
distribution of reads mapping to the 3′ UTR requires a good
coverage of that region. Hence, current methods are likely to
discover more events in libraries resulting from poly(A) selection
of RNA rather than the recently more popular ribosomal RNA
depletion kits, as the latter exhibit a bias against the 3′ end
which weakens the signal from APA events. Second, the samples
must be prepared from areas of the brain with predominantly
gray matter, as trends appear much weaker in a brain dataset
consisting primarily of white matter (Figure 2F). However,
which regions of the brain would be most suitable for observing
larger effects remains unknown. Third, the samples of a dataset
should be as closely matched as possible, because confounding
variables such as age and gender add unwanted variability in the
signal, likely concealing a small in magnitude but potentially
widespread across many genes signal. Moreover, differential
APA events may only be detectable at certain stages of brain
development but most datasets of post-mortem tissue inevitably
comprise a range of ages, potentially diluting the signal that could
be detected in a subset of these samples. Finally, post-mortem
samples are plagued by low quality issues due to degradation,
and such problems severely hinder the downstream analysis of
sequencing data.
Given the difficulty in predicting APA events from standard
RNA-seq data, we suggest that the initial test of this hypothesis
should focus on confirming dysregulation of the APA mechanism
using a method that measures a signal from the actual poly-
adenylation site. The majority of these methods work by
capturing the poly-adenylation tail of transcript fragments,
followed by sequencing a short segment of the nucleotides
directly attached to it. An advantage of these methods is that
they can discover novel events, including those that involve
lengthening of the 3
′
UTR beyond the longest known annotated
isoform (which is often used as the “reference” transcript in
computational methods searching for read density fluctuations
in RNA-seq data). Methods like PAS-seq (Shepard et al., 2011),
3′-seq (Jenal et al., 2012) or Poly(A)-seq (Derti et al., 2012) (and
others summarized in the review by Sun et al., 2012) would
be reasonable choices, although the protocols require special
expertise and these methods are not usually offered by services.
The introduction of kits that allow easy library preparation (such
as Lexogen’s QuantSeq) is a promising step toward making 3′
sequencing easily accessible to more labs. Direct RNA sequencing
(DRS) (Ozsolak et al., 2009), a single-molecule sequencing
approach that provides reads starting from the poly-adenylation
site is also appealing because it requires much smaller amounts
of RNA and avoids the PCR amplification step, which introduces
biases in the quantification of expression. DRS experiments have
been used to quantify differences in the use of alternative sites
(Ozsolak et al., 2010; Schurch et al., 2014) and are thus suitable
for testing our hypothesis. The more recent PAPERCLIP (Hwang
et al., 2016) method may be also an attractive alternative, largely
due to its potential for cell-type-specific 3′end mapping. A caveat
of using either RNA-seq or targeted 3′ sequencing data is that they
are both blind to post-transcriptional processing of RNA that
generates transcripts from the 3′ UTR, expressed independently
of the protein-coding part of the gene. The existence of such
transcripts has been suggested, backed up by both computational
and experimental evidence (Mercer et al., 2011). Methods that
detect and quantify the expression of full-length transcripts using
ultra-long reads (e.g., the technologies available from Pacific
Biosciences or Oxford Nanopore) would allow the detection of
these 3′ UTR RNAs and their consideration as separate species to
the traditional transcripts produced by the same gene locus.
It is important to point out that, for all the reasons stated at the
beginning of this section, isolating APA events identified in RNA-
seq data and testing for their presence in any but the samples in
which they have been actually observed is likely to be a pointless
exercise. However, if dysregulated events were found using a
more direct method such as DRS, then isolating genes with large
effect sizes and focusing on validating alternative isoforms with
qRT-PCR would be advisable.
The data presented in this study come from brain samples.
Post-mortem brain tissue is a valuable resource, not trivial to
access and of limited availability. It could be argued that blood-
derived samples would be easier to obtain but there is no evidence
they would recapitulate effects stemming from dysregulation of
signaling pathways in the brain. Moreover, there is evidence that
a limited number of transcripts are detectable in blood (GTEx
Consortium, 2015) making this medium a less appealing choice.
A number of mouse models carrying mutations or deletions
affecting ASD-linked genes are also available (Provenzano et al.,
2012). Although some researchers have debated the adequacy
of the mouse brain as a suitable model for complex diseases
(Miller et al., 2010), rodent models have been used successfully
in several studies of autism and related pathologies, including
the exploration of behavioral and physiological changes as well
as the testing of pharmacological interventions in Fmr1 (Gandhi
et al., 2014), Cntnap2 (Peñagarikano et al., 2011) and Tsc2
knock-out mice (Ehninger et al., 2008) (a comprehensive review
of such studies is given in (Crawley, 2012)). A viable alternative
to post-mortem tissue and animal models may be the use of
induced pluripotent stem (iPS) cells (Ardhanareeswaran et al.,
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 September 2017 | Volume 10 | Article 279
fnmol-10-00279 September 12, 2017 Time: 16:48 # 9
Szkop et al. Alternative Poly-adenylation Disruption in ASD
2017; Kathuria et al., 2017) or even mini-brains that are already
being used to probe serious neurological conditions (Kelava
and Lancaster, 2016) and are expected to become much more
accessible as model systems in the near future. We believe the
absence of confounding factors affecting the brain samples such
as medication, degradation of the tissue, and age of the donors
would make in vitro set ups a good platform on which to study
APA in the context of autism. Additionally, studies of this kind
allow for the use of small molecules that can modulate signaling
pathways (e.g., interfering with the calcium signaling processes),
thus making it easier to design experiments of the effect of
calcium dysregulation on APA.
POSSIBLE IMPLICATIONS OF APA
DYSREGULATION IN THE AUTISTIC
BRAIN
If a dysregulated signaling network affected the selection of
poly-adenylation site in the autistic brain, what would be the
implications of such dysregulation? One would expect changes
in the length of the 3′ UTR to have some effect on gene
expression, primarily through miRNA binding which might
be especially important in the brain, as this is the tissue
with the longest 3′ UTR and hence greatest potential for
miRNA regulation. As miRNA binding sites are commonly
found between APA sites (Sandberg et al., 2008; Hoffman
et al., 2016), an extension of the 3
′
UTR would be expected
to lead to the inclusion of more miRNA binding sites in the
transcripts, whereas shortening of the 3′ UTR would have the
opposite effect. Indeed, a search of the elongated parts of the
29 UTRs affected by APA in both the Ellis and Voineagu
datasets reveals at least one match to a miRNA binding site
in 13 of them (Supplementary Table 3). Because miRNAs act
mostly as repressors of gene expression, one could speculate that
the consequence of skipping the proximal site would be less
protein product for the affected transcripts. However, it cannot
be excluded that homeostatic mechanisms of gene expression
regulation would act to balance out the post-transcriptional
effects of abnormal poly-adenylation site selection and there
is evidence that changes in the isoform ratio due to APA are
not correlated to changes in gene expression (Lianoglou et al.,
2013). Moreover, miRNAs are not the only post-transcriptional
modulators. Additional searches of the 29 elongated parts
reveal the presence of a variety of UTR elements in 16 of
the genes and a large number of motifs that could be targets
of RNA-binding proteins in each of the 29 UTR extensions
(Supplementary Table 3). Although it is difficult to assign any
statistical significance to the presence of these motifs, we note
that many of the proteins associated with these motifs are
regulators of transcript processing, most prominently, alternative
splicing. The 3′ UTR length is also known to affect the rate
of mRNA decay although the relationship between the two
is not simple, as a recent study in yeast has revealed (Gupta
I. et al., 2014). Hence, not only the downstream effect on
the protein level, but also the effect of APA dysregulation on
mRNA stability could be debatable. An additional role of the
potential influence of APA (and by extension, its dysregulation),
on post-translational protein localization, independently of
mRNA localization, has been demonstrated in human cell lines
(Berkovits and Mayr, 2015). The suggested mechanism involves
the recruitment to the site of translation of protein factors
that interact with the 3′ UTR; these proteins then facilitate
the translocation of the newly translated protein to its final
destination. Disruption of this mechanism leads to altered
spatial distribution of the relevant protein products. In neurons,
where the morphology of the cell is complex, an improper
balance in spatial distribution can be expected to be particularly
detrimental.
We believe that the effect of APA dysregulation in the
brain will depend on (a) the extent of the disruption, (b) the
genetically determined ability of the individual to respond to and
correct such disruptions and (c) the interplay with other factors,
including medical conditions, environmental inputs etc. The
effect of environmental factors is a question of particular interest,
given existing studies linking environmental signals and APA in
plants (Shen et al., 2011). Potentially, more relevant to the human
brain is a study demonstrating that the estrogen 17-beta estradiol
(E2) induces APA and shortens the 3′ UTR of CDC6, resulting
in higher levels of the protein product that regulates DNA
replication (Akman et al., 2012). This study raises the question of
whether APA regulation may differ between males and females,
where E2 levels are higher, and whether such differences may
also play a role in the relationship between APA and autism,
given that this disorder has a strong prevalence among males.
The link between APA and estrogens in general could also
be worth investigating further in the context of the interplay
between genetics and environment. Given the increasing levels
of steroid estrogens in soil and water due to industrialization
(Adeel et al., 2017), the role of estrogen pollutants and their
potential link to aberrant APA in the brain may be worth
investigating.
Our analysis points to a number of small changes rather
than isolated APA events of significant magnitude, although we
reiterate here the caveats of relying on software rather than direct
experimental observation of the APA events. Small changes are
unlikely to lead to observable effects, except in cases where the
genetic make-up of the individual or a coexistent factor affects
the cell’s ability to cope with such disruptions. However, it is
possible for a large number of small changes to lead to some
observable effect, and this effect can occasionally be bigger than
the effect of a large change in a single gene (Mootha et al., 2003).
Importantly, it has been shown that inherited common genetic
variations act additively to increase the risk of ASD liability, so
the possibility of polymorphisms acting to amplify a small effect
in the context of this disorder is not far-fetched (Klei et al.,
2012).
If our hypothesis is true, it may have implications for the
early detection of ASD. It would be worth, for example, exploring
3′ UTR differences in other tissues to assess the potential for
building a classifier capable of good discrimination between
children affected by ASD and neurotypical children. Similarly,
exploring 3′ UTR differences in other brain disorders could
shed light on the question of how common APA dysregulation
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is among these diseases, and what, if any, are unique poly-
adenylation signatures for each condition. The recent study
by (Hollerer et al., 2016) suggesting increased usage of the
distal poly(A) sites in cell lines as a general response to stress
highlights the importance of exploring APA dysregulation in
other disorders.
CONCLUSION
We present here the hypothesis that the mechanism of APA
is dysregulated in the autistic brain, potentially contributing to
ASD pathology. We argue that the effect of dysregulated APA
selection will be determined by an individual’s genetic variations
and exposure to environmental factors, leading to a spectrum
of effects and phenotypes, many of which would be too hard
to predict without a solid understanding of the underlying
molecular networks. We hope our observations and suggestions
will stimulate further experiments in the field.
METHODS
Origin of RNA-seq Datasets
The data analyzed in this project originates from six publicly
available RNA–seq datasets (described in more detail below).
Samples that did not pass our pre- and post-mapping data quality
control (described below and in the next section) were removed.
In addition, we attempted to use “cleaner” datasets by removing
samples from individuals with questionable phenotypes or
samples that severely biased the distribution of ages in either
the condition or the control groups. One dataset (“Ellis”) had
a very large number of samples but different areas of the brain
were sampled and in some cases samples originated from the
same individual. In this case, we kept only one sample per
individual, to avoid biasing the group, and used only samples
from the same area of the brain to minimize within-group
biological differences. Briefly, our exclusion criteria were: (a)
samples were removed, if they failed the quality control for
sequencing bias [mean TIN value (a measure of transcript
integrity equivalent approximately to RIN value × 10) across
all transcripts < 40], (b) samples originating from teenager
individuals in the Ellis dataset were removed as they were all
in the control group with no corresponding-age samples in the
autistic group, (c) all samples originating from any area except
BA19 were removed from the Ellis dataset (because we did
not want to have to factor in changes due to different regions
of the brain), (d) all samples discarded in the original study
of (Ellis et al., 2013) or in the subsequent study of the same
group of authors using the same data (Gupta S. et al., 2014)
were discarded here too, and (e) a handful of isolated samples
for which information was available that showed the use of
medication for disorders comorbid with autism were removed
(to avoid including undiagnosed ASD cases as controls as well
as ASD cases that would have their transcriptomes potentially
severely affected by the use of drugs). Four of the datasets
contained post-mortem brain samples from both healthy and
ASD individuals. The Voineagu dataset comprises 2 autistic and
3 control samples from Brodmann areas 9, 22 and 41 (cerebral
cortex) (Voineagu et al., 2011). The Ellis dataset contains 9
autistic and 16 control post-mortem brain samples, all from
Brodmann area 19 of the occipital lobe cortex (Ellis et al.,
2013). The Li dataset includes 6 autistic and 6 control samples
from the corpus callosum, an area of the brain that consists
predominantly of white matter (Li et al., 2014). The Irimia
dataset comprises brain samples from Brodmann areas 41, 42
and 22 (each sample comprising a mixture of all three areas)
from 12 autistic and 12 healthy individuals (Irimia et al., 2014).
In addition to the above datasets, we used the Mills dataset of
brain samples from 3 healthy individuals (Mills et al., 2015)
for a comparison of APA differences between gray and white
matter. Finally, we used the Fong dataset (Fong et al., 2014) to
examine APA in isogenic human HEK293 cell lines representing
RNA polymerase II mutants with accelerated and slowed down
kinetics.
Data Quality Control, Pre-processing and
Alignment
The raw reads from all datasets were checked for quality
using FastQC-v0.11.3 (FastQC, RRID:SCR_014583). Parts of
the reads with low quality (defined as an average quality per
base dropping below 15) and all synthetic parts of sequences,
such as adaptors, that were unintentionally included during the
sequencing process were trimmed using Trimmomatic v0.32
(Bolger et al., 2014). All the reads were uniquely mapped
to the reference human genome (UCSC hg19 version) using
Tophat2-v2.0.14 (Kim et al., 2013). Reads containing parts of
the poly(A)-tail cannot be mapped to the reference genome
during this first mapping round. Hence, stretches of at least
three adenosines were trimmed from the end of these reads
using FQtrim v.0.94 (FQtrim, doi: 10.5281/zenodo.20552) and
the processed reads were mapped to the genome once again.
PCR duplicates were removed with Picard-tools-v1.114 (Picard,
RRID:SCR_006525). Finally, the output files were checked with
RSeQC-v2.6.2 (Wang et al., 2012), particularly with the aim
of looking for potential 3′ or 5′ bias that might indicate high
RNA degradation level. In addition, TIN values for each sample
were calculated as described in RSeQC. Samples with mean TIN
values below 40 (after removal of zeros) were removed from the
datasets. Moreover, individual transcripts were removed, if the




Prepared files containing mapped reads were converted to
bedgraph format using Bedtools v2.17.0 (Quinlan and Hall,
2010) and these were used as input for the software DaPars-
v.0.9 (Masamha et al., 2014; Xia et al., 2014). DaPars
discovers statistically significant alternative poly-adenylation
events between two groups of samples (e.g., ASD vs. healthy,
or white vs. gray matter etc). It predicts proximal sites using
the drop in the number of reads near the site as a signal in a
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two-point model. In order to verify the validity of the DaPars-
predicted proximal sites, a custom-made computational pipeline
was applied that identifies high-confidence poly(A) sites by
searching for the presence of reads with poly(A) tails terminating
near the predicted site.
Meta-Analysis of Gene Lists
Gene ontology analysis and Reactome pathway enrichment were
carried out using GOseq (Young et al., 2010) to account for
selection bias between long and short genes in RNA-seq. Where
a background set of genes was required for enrichment analysis,
we defined a subset of genes with detectable expression in each
dataset. To define this subset, we estimated the expression of
each gene calculating transcripts per million (TPM) values from
raw counts, and considered expressed only those with median
TPM > 1.
Gene set enrichment analysis (Subramanian et al., 2005) was
carried out using the server available at the Broad Institute1 and
the “hallmark gene sets” from the Molecular Signatures Database
(v. 5.1). Instead of expression values, PDUI values of genes were
used as input. The standard KS statistic was applied to all gene
sets having at least 10 tested genes. All other settings were set
to default values. The software Dreme (Bailey, 2011) from the
MEME suite (Bailey et al., 2009) was used to look for over-
represented motifs in the following regions: (a) 50 nucleotides
upstream of the predicted proximal and annotated distal sites,
(b) the region between the proximal and distal sites and (c) the
region between the start of the last exon and the proximal site.
In addition, motifs were searched 20000 nucleotides upstream
of annotated transcription start sites and 20000 nucleotides
downstream of annotated distal sites.
The program fuzznucc from the EMBOSS tools (Rice et al.,
2000) (version 6.3.1, available from the Mobyle Pasteur server
(Néron et al., 2009) was used to search for the presence of the CRE
motif (TGACGTCA) or its complement in the upstream regions
(20000 nucleotides upstream of the transcription start site) of (a)
the genes with significant APA events (adjusted p-values < 0.05
from DaPars and PDUI group difference > 0.2) and (b) all
expressed genes in the Ellis and Voineagu datasets.
The sequence between proximal and distal poly-adenylation
site in the 3′ UTR of the 29 genes with statistically significant
differential APA events in both the Ellis and Voineagu datasets
was used in a series of searches for regulatory elements. The
RBPmap (Paz et al., 2014) web server2 was used to find RNA-
binding protein target motifs. The UTRScan (Grillo et al., 2010)
tool3 was used to find UTR elements. Finally, miRNA binding
sites were retrieved from the results of TargetScan (Lewis et al.,
2005) available from the UCSC genome browser (Kent et al.,
2002).
Lists of synaptic and post-synaptic density proteins from
(Bayés et al., 2011) were obtained from the Arking group





from (McKee et al., 2007). We kept only genes with adjusted
p-value < 0.005 (cut-off suggested in the original paper) and
converted the original RefSeq IDs to gene names using the gene
ID converter of the DAVID online server (Huang da et al.,
2009).
Significance tests were carried out and plots were created
using the R statistical software suite (R Core Team, 2015).
Adjustment of p-values for multiple testing was carried
out throughout using the Benjamini–Hochberg procedure, as
implemented in R.
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